British Technology Group (BTG)

Discussion in 'Pinnacle Biologics' started by Anonymous, Nov 20, 2012 at 10:08 AM.

  1. Anonymous

    Anonymous Guest

    Let's see...we're in February and the sale has yet to be announced. What's a matter BTG? Getting cold feet on this deal? I encourage BTG to move forward with the purchase. Just imagine the example the FDA can make out of these two companies. It may appear as if the FDA is dragging their feet with all that has been brought to their attention. My source has assured me otherwise.
     

  2. Anonymous

    Anonymous Guest

    They want us going to see off-label cases for cholangiocarcinoma. Are these people serious?! Apparently, it's a "suggested" activity by the President of Pinnacle and Brad Herman. If my company ends up purchasing this ridiculous product, I'm out of here.
     
  3. Anonymous

    Anonymous Guest

    I was trained by BTG for Photofrin by going to see off-label PDT cases. Why? PDT is done for anything else?
     
  4. Anonymous

    Anonymous Guest

    Looks like the deal fell through! Guess BTG wised up!
    Whoever comes next, I hope they realize what a slime-balls these guys are!
     
  5. Anonymous

    Anonymous Guest

    Man, that was a close call. I would have resigned from BTG had they purchased Photofrin from G. Herrera. Something didn't feel right, from the beginning. BTG management had more information which they weren't willing to share with the sales force. They made the wise decision to not move forward.